Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Chen, Jin Lian ^a   Fan, Jing ^b   Chen, Ming Xiang ^b   Dong, Ying ^b   Gu, Jian Zhong ^c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEPARIN DERIVATIVE; MESSENGER RNA; N DESULFATED HEPARIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENSITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; METASTASIS; METASTASIS INHIBITION; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STOMACH CARCINOMA;

EID: 84864922734     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/752940     Document Type: Article

References (34)

1. Carmeliet P., Jain R. K., Angiogenesis in cancer and other diseases Nature 2000 407 6801 249 257
2. Maxwell P. H., Dachs G. U., Gleadle J. M., Nicholls L. G., Harris A. L., Stratford I. J., Hankinson O., Pugh C. W., Ratcliffe P. J., Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Proceedings of the National Academy of Sciences of the United States of America 1997 94 15 8104 8109 (Pubitemid 27343784)
3. Mader J. S., Smyth D., Marshall J., Hoskin D. W., Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells The American Journal of Pathology 2006 169 5 1753 1766 (Pubitemid 351182006)
4. Lee H. J., Lee E. O., Rhee Y. H., Ahn K. S., Li G. X., Jiang C., L J., Kim S. H., An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis Carcinogenesis 2006 27 12 2455 2463 (Pubitemid 44884103)
5. Vucenik I., Passaniti A., Vitolo M. I., Tantivejkul K., Eggleton P., Shamsuddin A. M., Anti-angiogenic activity of inositol hexaphosphate (IP6) Carcinogenesis 2004 25 11 2115 2123 (Pubitemid 39534848)
6. Zhao H., Liu H., Chen Y., Xin X., Li J., Hou Y., Zhang Z., Zhang X., Xie C., Geng M., Ding J., Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis Cancer Research 2006 66 17 8779 8787 (Pubitemid 44449195)
7. Javerzat S., Auguste P., Bikfalvi A., The role of fibroblast growth factors in vascular development Trends in Molecular Medicine 2002 8 10 483 489
8. Ribatti D., The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review British Journal of Haematology 2005 128 3 303 309 (Pubitemid 40216151)
9. Jung Y. D., Mansfield P. F., Akagi M., Takeda A., Liu W., Bucana C. D., Hicklin D. J., Ellis L. M., Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model European Journal of Cancer 2002 38 8 1133 1140 (Pubitemid 34468020)
10. Reinmuth N., Parikh A. A., Ahmad S. A., Liu W., Stoeltzing O., Fan F., Takeda A., Akagi M., Ellis L. M., Biology of angiogenesis in tumors of the gastrointestinal tract Microscopy Research and Technique 2003 60 2 199 207 (Pubitemid 36125708)
11. Falanga A., Marchetti M., Heparin in tumor progression and metastatic dissemination Seminars in Thrombosis and Hemostasis 2007 33 7 688 694 (Pubitemid 350157013)
12. Stevenson J. L., Varki A., Borsig L., Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects Thrombosis Research 2007 120 supplement 2 S107 S111
13. Naggi A., Casu B., Perez M., Torri G., Cassinelli G., Penco S., Pisano C., Giannini G., Ishai-Michaeli R., Vlodavsky I., Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting Journal of Biological Chemistry 2005 280 13 12103 12113
14. Chen J. L., Chen W. X., Zhu J. S., Chen N. W., Zhou T., Yao M., Zhang D. Q., Wu Y. L., Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function World Journal of Gastroenterology 2003 9 7 1607 1610 (Pubitemid 36992366)
15. Lang S. A., Klein D., Moser C., Gaumann A., Glockzin G., Dahlke M. H., Dietmaier W., Bolder U., Schlitt H. J., Geissler E. K., Stoeltzing O., Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo Molecular Cancer Therapeutics 2007 6 3 1123 1132 (Pubitemid 46554583)
16. Wang N., Wang B., Wang Y. J., Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice Ai Zheng 2006 25 9 1076 1081
17. Wu Y. L., Fu S. L., Zhang Y. P., Qiao M. M., Chen Y., Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts Biomedicine and Pharmacotherapy 2005 59 supplement 2 S289 S292
18. Pisano C., Aulicino C., Vesci L., Casu B., Naggi A., Torri G., Ribatti D., Belleri M., Rusnati M., Presta M., Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist Glycobiology 2005 15 2 1C 6C (Pubitemid 40227915)
19. Casu B., Guerrini M., Guglieri S., Naggi A., Perez M., Torri G., Cassinelli G., Ribatti D., Carminati P., Giannini G., Penco S., Pisano C., Belleri M., Rusnati M., Presta M., Undersulfated and glycol-split heparins endowed with antiangiogenic activity Journal of Medicinal Chemistry 2004 47 4 838 848 (Pubitemid 38176787)
20. Zhou T., Chen J. L., Song W., Wang F., Zhang M. J., Ni P. H., Geng J. G., Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats World Journal of Gastroenterology 2002 8 5 897 900
21. Lee D. Y., Kim S. K., Kim Y. S., Son D. H., Nam J. H., Kim I. S., Park R. W., Kim S. Y., Byun Y., Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate Journal of Controlled Release 2007 118 3 310 317 (Pubitemid 46441550)
22. Jayson G. C., Gallagher J. T., Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells British Journal of Cancer 1997 75 1 9 16 (Pubitemid 27007267)
23. Norrby K., 2.5kDa and 5.0kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEFG 165 -mediated mammalian angiogenesis International Journal of Experimental Pathology 2000 81 3 191 198 (Pubitemid 30485818)
24. Ono K., Ishihara M., Ishikawa K., Ozeki Y., Deguchi H., Sato M., Hashimoto H., Saito Y., Yura H., Kurita A., Maehara T., Periodate-treated, non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) affects angiogenesis and inhibits subcutaneous induced tumour growth and metastasis to the lung British Journal of Cancer 2002 86 11 1803 1812 (Pubitemid 34712927)
25. Mousa S. A., Mohamed S., Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy Oncology Reports 2004 12 4 683 688
26. Vlodavsky I., Fuks Z., Ishai-Michaeli R., Bashkin P., Levi E., Korner G., Bar-Shavit R., Klagsbrun M., Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis Journal of Cellular Biochemistry 1991 45 2 167 176
27. Cronauer M. V., Hittmair A., Eder I. E., Hobisch A., Culig Z., Ramoner R., Zhang J., Bartsch G., Reissigl A., Radmayr C., Thurnher M., Klocker H., Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate Prostate 1997 31 223 233 (Pubitemid 27247313)
28. Birck A., Kirkin A. F., Zeuthen J., Hou-Jensen K., Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients Melanoma Research 1999 9 4 375 381 (Pubitemid 29407070)
29. Sartippour M. R., Zhang L., Lu M., Wang H. J., Brooks M. N., Nipple fluid basic fibroblast growth factor in patients with breast cancer Cancer Epidemiology Biomarkers and Prevention 2005 14 12 2995 2998 (Pubitemid 43068837)
30. Barclay C., Li A. W., Geldenhuys L., Baguma-Nibasheka M., Porter G. A., Veugelers P. J., Murphy P. R., Casson A. G., Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene Clinical Cancer Research 2005 11 21 7683 7691 (Pubitemid 41611610)
31. Hatziapostolou M., Polytarchou C., Katsoris P., Courty J., Papadimitriou E., Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells Journal of Biological Chemistry 2006 281 43 32217 32226 (Pubitemid 46036776)
32. Pardo O. E., Wellbrock C., Khanzada U. K., Aubert M., Arozarena I., Davidson S., Bowen F., Parker P. J., Filonenko V. V., Gout I. T., Sebire N., Marais R., Downward J., Seckl M. J., FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKC, B-Raf and S6K2 EMBO Journal 2006 25 13 3078 3088 (Pubitemid 44106760)
33. Zhao J., Liu X. Y., Zhang Q. Y., Jiang W., Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer Zhonghua Zhong Liu Za Zhi 2005 27 11 676 679
34. Yonemaru K., Sakai H., Murakami M., Yanai T., Masegi T., Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors Veterinary Pathology 2006 43 6 971 980 (Pubitemid 44785970)